Stay updated on Locally Advanced Lung Cancer Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page.

Latest updates to the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has undergone significant updates, including the addition of the study title 'Phase II Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC): BTCRC-LUN16-081' and the revision number has been updated from v2.14.4 to v2.15.0. Additionally, the collaborators have been specified as Bristol-Myers Squibb and the Big Ten Cancer Research Consortium.SummaryDifference54%
- Check38 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding two new dates: March 11, 2025, and February 6, 2025.SummaryDifference0.4%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has been updated to include new results reporting dates and definitions for key clinical trial metrics, such as Progression Free Survival (PFS) and Time to Metastatic Disease (TTMD), while removing outdated information regarding recruitment status and previous reporting dates.SummaryDifference8%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Locally Advanced Lung Cancer Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page.